首页 › 弥漫性大B细胞淋巴瘤 › 得克萨斯州 › San Antonio
San Antonio TX 弥漫性大B细胞淋巴瘤临床试验
8项针对 弥漫性大B细胞淋巴瘤的研究正在 San Antonio及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
招募中1 期
- University Hospital System, San Antonio
- University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
招募中2 期
- Texas Oncology - San Antonio ( Site 8009), San Antonio
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
招募中2 期
- Texas Transplant Institute, San Antonio
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- Texas Transplant Institute, San Antonio
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- Texas Transplant Institute, San Antonio
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Texas Transplant Institute, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
招募中2 期
- University of Texas Health Science Center at San Antonio, San Antonio
其他城市的 弥漫性大B细胞淋巴瘤试验
- New York City, NY21 项研究
- Baldwin Park, CA19 项研究
- Chicago, IL18 项研究
- Los Angeles, CA17 项研究
- Houston, TX17 项研究
- Boston, MA16 项研究
- Milwaukee, WI16 项研究
- Portland, OR15 项研究
- Philadelphia, PA15 项研究
- Durham, NC14 项研究
- Nashville, TN14 项研究
- Dallas, TX13 项研究
San Antonio的其他研究
- 非小细胞肺癌59 项研究
- 结直肠癌46 项研究
- 乳腺癌46 项研究
- 转移性癌症44 项研究
- 癌症（所有类型）41 项研究
- 肥胖症39 项研究
- 2型糖尿病37 项研究
- 超重33 项研究
- 胰腺癌31 项研究
- 卵巢癌31 项研究
- 前列腺癌28 项研究
- 子宫内膜癌27 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。